Capstone Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Sell
5,400
-1,000
-16% -$78.9K ﹤0.01% 1266
2025
Q4
$525K Sell
6,400
-6,200
-49% -$483K ﹤0.01% 1133
2025
Q3
$946K Buy
12,600
+3,500
+38% +$261K ﹤0.01% 1057
2025
Q2
$674K Sell
9,100
-4,100
-31% -$285K ﹤0.01% 1009
2025
Q1
$1.07M Buy
13,200
+2,900
+28% +$249K ﹤0.01% 870
2024
Q4
$805K Buy
10,300
+6,700
+186% +$570K ﹤0.01% 1143
2024
Q3
$338K Buy
3,600
+1,800
+100% +$151K ﹤0.01% 1363
2024
Q2
$140K Buy
+1,800
New +$147K ﹤0.01% 1838

Other funds holding GEHC

Capstone Investment Advisors's GEHC Position: Q1 2026 in Review

Capstone Investment Advisors reduced its GE HealthCare (GEHC) stake by 56% in Q1 2026, selling an estimated $489K and leaving 4,781 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

Capstone Investment Advisors first reported a position in GEHC in Q3 2023 and has held it in 11 quarters since. The position peaked at $48.3M in Q1 2024. 1,267 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Capstone Investment Advisors held 4,781 shares of GE HealthCare worth $340K as of Q1 2026.
  • Capstone Investment Advisors sold 6,201 GE HealthCare shares in Q1 2026, an estimated $489K.
  • GE HealthCare made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1313 holding.
  • Capstone Investment Advisors first reported a position in GE HealthCare in Q3 2023 and has held it in 11 quarters since.
  • Capstone Investment Advisors's GE HealthCare position peaked at $48.3M in Q1 2024.
  • 1,267 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.